Developmental neurotoxicity testing with human embryonic stem cell-derived in vitro systems: the novel FP7 ESNATS tests are available.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Avoiding a reproducibility crisis in regulatory toxicology-on the fundamental role of ring trials.Archives of toxicology · 2024
   Article
2. The Future of the Teratogenicity Testing.Methods in molecular biology (Clifton, N.J.) · 2024
   Review
3. Expression classifiers for developmental toxicants.EXCLI journal · 2015
   Article
4. Biomarker: the universe of chemically induced gene expression alterations in human hepatocyte.EXCLI journal · 2014
   Article
5. The body-on-a-chip concept: possibilities and limitations.EXCLI journal · 2014
   Article
6. In vitro test systems and their limitations.EXCLI journal · 2013
   Article
7. Transcriptomics in developmental toxicity testing.EXCLI journal · 2013
   Article

Corrections and comments

• Comment on
  Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach.2013

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as